Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (41 ops.)
Latest filing published 09 Sept 2026 for Relay Therapeutics, Inc., €139k. Read the official filing
Filing timeline
BuySaleDonald A. Bergstrom
Insider track record
Disclosed buys
0
Disclosed sells
41
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Donald A. Bergstrom: trading record in brief
All filings by Donald A. Bergstrom on record concern Relay Therapeutics, Inc., in the capacity of chief executive. We count 61 filings; the first trade dates from 16 June 2021 and the latest from 8 September 2026.
Every open-market trade on record is a sale: 41 sales worth €2.5M. The totals do not cover 1 filing with an undisclosed amount. The rest of the record consists of 4 share grants and 16 option exercises. 2026 to date brings no purchases and 6 sales.
The latest filing, published on 9 September 2026, reports an open-market sale of €139k in Relay Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Donald A. Bergstrom
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations61 total
8,530 shares@ US$18.97Common StockSEC:0001193125-26-386473:0
2,237 shares@ US$18.610.0011% mcap2.1% of flowCommon StockSEC:0001193125-26-326137:0
8,660 shares@ US$18.710.0040% mcap5.8% of flowCommon StockSEC:0001193125-26-298688:0
93,456 sharesCommon StockSEC:0001193125-26-281059:0
93,456 sharesCommon StockSEC:0001193125-26-281059:1
1,490 shares@ US$14.790.0005% mcap0.8% of flowCommon StockSEC:0001193125-26-197395:0
18,895 shares@ US$7.627.3% of flowCommon StockSEC:0001193125-26-029415:0
30,897 shares@ US$7.2912.5% of flowCommon StockSEC:0001193125-25-258557:0
4,069 shares@ US$3.741.0% of flowCommon StockSEC:0000950170-25-100365:0
4,090 shares@ US$3.170.5% of flowCommon StockSEC:0000950170-25-061365:0
27,472 shares@ US$3.003.2% of flowCommon StockSEC:0000950170-25-061365:1
986 shares@ US$2.840.1% of flowCommon StockSEC:0000950170-25-047762:0
3,220 shares@ US$4.630.6% of flowCommon StockSEC:0000950170-25-011319:0
657 shares@ US$4.380.1% of flowCommon StockSEC:0000950170-24-141598:0
2,688 shares@ US$6.060.7% of flowCommon StockSEC:0000950170-24-118981:0
648 shares@ US$7.510.2% of flowCommon StockSEC:0000950170-24-110808:0
2,698 shares@ US$8.851.0% of flowCommon StockSEC:0000950170-24-088812:0
648 shares@ US$6.260.2% of flowCommon StockSEC:0000950170-24-079692:0
2,686 shares@ US$6.380.7% of flowCommon StockSEC:0000950170-24-050146:0
765 shares@ US$7.700.2% of flowCommon StockSEC:0000950170-24-038656:0
3,178 shares@ US$9.641.2% of flowCommon StockSEC:0001209191-24-002470:0
300,000 shares0Common StockSEC:0001209191-24-001837:0
977 shares@ US$11.510.4% of flowCommon StockSEC:0001209191-23-059996:0
3,451 shares@ US$6.030.9% of flowCommon StockSEC:0001209191-23-054020:0
1,228 shares@ US$10.680.7% of flowCommon StockSEC:0001209191-23-050869:0
25 of 61 declarations
